Alemtuzumab

Brand Name

Campath®

Company

Ilex/Berlex

Class

• Humanized rodent monoclonal antibody against the CD-52 expressed on both B and T lymphocytes

Mechanism of Action

• Antibody and cell mediated lysis of B and T lymphocytes

Indication

• Primary: Treatment of chronic B cell lymphocytic leukemia

• Chills shortly after infusion

Formulation

• 30 mg vials

Dosage

• up to 30 mg daily

Acknowledgment:

0 0

Post a comment